Brazilian hemorrhagic fever is a very rare viral illness. It is caused by the Sabiá mammarenavirus (SABV), an arenavirus found in South America. People usually get infected after contact with infected rodents or their droppings. The disease can lead to bleeding, low blood pressure, shock, and sometimes death. Only a handful of human cases have ever been recorded, including some infections in laboratories. Canada.ca+2cdc.gov+2
Brazilian hemorrhagic fever is a very rare but severe viral illness caused by Sabiá mammarenavirus, an arenavirus first identified near São Paulo, Brazil. Early symptoms are fever, headache, muscle pain, and weakness. After several days, some patients develop bleeding (hemorrhage) from the gums or nose, red eyes, easy bruising, vomiting blood, and sometimes confusion, tremors, or seizures. Severe cases can progress to shock, organ failure, and death within 2–3 weeks. Only a handful of human cases have ever been confirmed, but the illness is serious enough that laboratories classify the virus as Risk Group-4 (maximum containment). There is no specific, FDA-approved antiviral cure; treatment focuses on supportive critical care, strict infection control, and—in limited, case-by-case situations—off-label antivirals under expert guidance. Canada.ca+2sciencedirect.com+2
Brazilian hemorrhagic fever is a severe infection that starts like the flu. People get fever, body aches, sore throat, and stomach upset. Within a few days, some patients develop bleeding from the nose or gums, red eyes, and a rash of tiny red spots. The virus can damage small blood vessels and organs like the liver. This damage can cause low blood pressure, confusion, and shock. Without expert care in a special hospital, the disease can be fatal. The illness is so rare that most information comes from a few case reports and public-health summaries. Canada.ca+1
Scientists group Sabiá virus with the South American arenaviruses that can also cause hemorrhagic fever, such as Junín, Machupo, and Guanarito. These viruses are carried by certain wild mice. sciencedirect.com+1
Other names
Brazilian hemorrhagic fever may also be called:
Sabiá virus disease or SABV infection (the name of the virus that causes it). Canada.ca
BzHF (an abbreviation sometimes used in reports). Wikipedia
Sabiá mammarenavirus hemorrhagic fever (a scientific, family-level name). Canada.ca
Types
Doctors do not use formal types like “Type 1, Type 2” for this disease. But for teaching and planning care, they often think about BHF in three practical ways:
Primary (natural) infection
A person is infected in nature, likely after breathing in dust or touching items contaminated with infected rodent urine or droppings. This is how most South American arenaviruses spread to humans. cdc.govLaboratory-acquired infection
Health or research workers can be infected in a lab if safety steps fail. One U.S. virologist caught SABV during work and was treated in a high-containment setting. nejm.org+1Nosocomial (hospital) exposure risk
Close contact with a very sick patient’s blood or body fluids in a hospital could spread the virus. Strict infection-control rules are used, similar to other viral hemorrhagic fevers. Cambridge University Press & Assessment
Causes
Note: The single cause is infection with Sabiá virus. The items below describe exposure situations that can lead to that infection.
Contact with rodent droppings in homes or barns
Rodent urine or feces can hold arenaviruses. Touching or cleaning these areas without protection may spread virus to the mouth, nose, or eyes. cdc.govBreathing dust where infected rodents live
Sweeping dry, contaminated spaces can make tiny particles of rodent waste become airborne. Breathing that dust may cause infection. cdc.govHandling rodent nests or traps
Moving nests or dead rodents without gloves can put virus on the hands and then the face. cdc.govEating food contaminated by rodents
Food stored in open bags can be tainted by rodent urine or droppings. cdc.govWorking in grain storage or rural sheds
These places often attract rodents. Dust and droppings raise the risk if safety steps are not used. cdc.govSleeping in rodent-infested buildings
Nighttime exposure in cabins or farmhouses increases contact risk. cdc.govCleaning after floods or heavy rains
Rodents may move indoors; cleanup can stir up contaminated dust. cdc.govFieldwork in endemic areas
Farmers and outdoor workers may meet contaminated soil or dust. cdc.govHunting or handling wild rodents
Direct handling raises exposure to blood or body fluids. cdc.govLaboratory accidents
Needlestick, splash, or aerosol exposure in research labs can transmit SABV. nejm.org+1Improper lab biosafety level
Working with arenaviruses outside proper BSL-3/4 controls can create aerosols and risks. Canada.caHealthcare exposure without proper PPE
Caring for a patient with hemorrhagic fever without gloves, gown, mask, and eye protection may spread infection. Cambridge University Press & AssessmentHandling patient samples without containment
Blood or tissue from a suspected case must be processed in high-containment labs. Canada.caSharing needles or sharp instruments
Reuse or injuries with contaminated sharps can transmit the virus. Canada.caClose contact with heavy body-fluid exposure
Splash from vomit, blood, or stool in severe cases can pose risks. Canada.caUnprotected mortuary care
Handling remains without precautions can expose workers to infectious fluids. Canada.caTravel to affected regions with rodent exposure
Travelers staying in rural homes or barns may be exposed if rodents are present. cdc.govUnrecognized outbreaks in nature
Arenaviruses can circulate silently in rodents; a person may be exposed without realizing the risk. CFSPHContaminated clothing or bedding
Items in rodent-infested buildings can carry virus until cleaned well. cdc.govBiological aerosol generation in high-risk settings
Certain lab procedures and power cleaning can make infectious aerosols. Canada.ca
Symptoms
Fever
A sudden or gradual rise in temperature is common. Fever is the body’s sign that it is fighting a viral infection. Canada.caHeadache
The virus and the body’s immune response can inflame tissues, causing head pain and pressure. Canada.caMuscle and joint aches (myalgia/arthralgia)
Inflammation and dehydration often cause deep aches and soreness. Canada.caSore throat and cough
The upper airways can be irritated early in the illness, making swallowing or breathing uncomfortable. Canada.caStomach pain
Inflammation of the gut lining and liver irritation can cause upper belly pain. Canada.caNausea and vomiting
These symptoms are common in many viral hemorrhagic fevers and worsen dehydration. rarediseases.info.nih.govDiarrhea
Loose stools may occur and can contain blood in severe cases. This leads to fluid and salt loss. Canada.caRed eyes (conjunctival injection) and tiny red spots
Small vessel injury can cause red eyes and pinpoint skin bleeding (petechiae). rarediseases.info.nih.govBleeding from gums or nose
Low platelets and damaged blood vessels can lead to bleeding even without injury. rarediseases.info.nih.govRash or bruising
Leaky small vessels can make red or purple patches on the skin. Canada.caWeakness and fatigue
Inflammation, fever, and poor intake drain energy and make people feel very tired. Canada.caConfusion or drowsiness
Low blood pressure, liver involvement, or electrolyte problems can affect the brain. Canada.caLow urine output
Dehydration and shock reduce kidney blood flow, so less urine is made. Canada.caShortness of breath
Fluid in the lungs, pneumonia, or shock can make breathing hard. Canada.caWorsening to shock
In severe disease, blood pressure falls, organs fail, and urgent critical care is needed. Canada.ca
Diagnostic tests
A) Physical examination (bedside assessment)
Vital signs
Doctors check temperature, heart rate, breathing rate, and blood pressure. Fever and fast heart rate are common; low blood pressure is a danger sign for shock. Canada.caHydration check
Dry mouth, fast pulse, and low urine suggest dehydration. This guides fluid treatment. Canada.caSkin and mucosa check for bleeding
Doctors look for petechiae, bruises, gum bleeding, and nosebleeds. These are classic hemorrhagic signs. rarediseases.info.nih.govEye exam
Red eyes (conjunctival injection) or small hemorrhages can be seen. This supports the diagnosis when combined with other findings. rarediseases.info.nih.govAbdomen and liver-spleen exam
Tenderness in the upper right belly and enlarged liver or spleen may occur and help judge severity. Canada.ca
B) Manual or bedside tests and scores
Orthostatic blood pressure test
Falling pressure on standing suggests low blood volume. It helps detect early shock. Canada.caCapillary refill time
Pressing on a fingernail to see how fast color returns checks blood flow to tissues. Slow refill suggests poor perfusion. Canada.caGlasgow Coma Scale (GCS)
A simple score of eye, verbal, and motor response checks brain function when a patient seems confused or very ill. Canada.caBedside bleeding assessment
Careful pressure hold after a needle stick and close observation for oozing help judge bleeding risk before any procedures. Canada.ca
C) Laboratory and pathological tests
Complete blood count (CBC)
Many patients show low platelets and low white cells. This supports a viral hemorrhagic process. nejm.org+1Liver enzymes (AST/ALT) and bilirubin
The liver can be inflamed, so these labs rise. They help track severity. Canada.caKidney function (creatinine, urea) and electrolytes
Shock and dehydration can impair kidneys and upset salts. These tests guide fluids and care. Canada.caCoagulation panel (PT/INR, aPTT, fibrinogen, D-dimer)
These tests measure clotting. Abnormal results point to a bleeding disorder and help manage transfusions. Canada.caSerum lactate and blood gases
High lactate suggests poor blood flow to tissues. Blood gases help assess breathing failure. Canada.caRT-PCR for Sabiá virus RNA
A specialized test detects the virus’s genetic material in blood or other samples. This confirms the diagnosis and must be done in a high-containment lab. Canada.caSerology (IgM/IgG antibodies)
ELISA or other methods can show recent or past infection. These tests also need specialized, secure facilities. Canada.caVirus isolation (only in BSL-4/3+)
Growing the virus is rarely needed for care but is used in research and public health. It requires top-level biosafety. Canada.caOther pathogen tests to rule out similar diseases
Doctors check for dengue, yellow fever, leptospirosis, malaria, and bacterial sepsis because symptoms overlap. This helps avoid missed diagnoses. Canada.ca
D) Electrodiagnostic tests
Electrocardiogram (ECG)
Severe infection and shock can stress the heart. An ECG looks for rhythm problems or strain that may need treatment. Canada.caElectroencephalogram (EEG) when confusion or seizures occur
If brain function is affected, EEG can help detect seizures or diffuse brain irritation. This supports care in the intensive care unit. Canada.ca
E) Imaging tests (often used alongside the tests above)
Chest X-ray
Looks for pneumonia, fluid in the lungs, or acute lung injury in very ill patients. Findings help guide oxygen or ventilation support. Canada.caBedside ultrasound (point-of-care)
Checks fluid status (e.g., IVC size), liver and spleen size, and presence of abdominal fluid. It is fast and avoids moving unstable patients. Canada.caAbdominal ultrasound or CT
Evaluates liver injury, spleen size, and bleeding. Doctors choose CT only when it is safe and useful. Canada.caBrain CT/MRI (if severe headache, confusion, or seizures)
Rules out bleeding or swelling in the brain in patients with neurological symptoms. Canada.ca
Non-pharmacological treatments (therapies & other measures)
These are supportive/critical-care practices. They don’t kill the virus, but they keep the body alive while the immune system fights.
Strict isolation & PPE (barrier nursing)
Description: Patients are placed in single, well-ventilated rooms (ideally negative pressure). Staff use PPE (impermeable gown, gloves, N95 or higher respirator, face/eye protection). Surfaces and spills are disinfected with appropriate agents. Waste is handled as high-risk. Transport is minimized, and procedures are done in-room when possible. Purpose: Protect staff and other patients; prevent hospital outbreaks. Mechanism: The virus spreads via contact with infected blood/body fluids or contaminated surfaces. PPE and isolation interrupt exposure, lowering transmission risk. cdc.gov+1Aggressive fluid & electrolyte management
Description: Frequent checks of blood pressure, pulse, urine output, and labs guide oral rehydration (ORS) if safe, or IV fluids if not. Balanced solutions and careful electrolyte replacement (sodium, potassium) are used. Purpose: Prevent or treat dehydration and shock. Mechanism: Fever, vomiting, and capillary leak cause fluid loss and low blood pressure; fluids restore circulating volume so organs get oxygen. World Health Organization+1Oral rehydration solution (ORS) when tolerated
Description: Sips of reduced-osmolarity ORS (the WHO formula) are encouraged if the patient can drink safely and is not vomiting uncontrollably. Purpose: Replace fluid and salts without an IV; lighten nursing workload in PPE. Mechanism: The glucose-sodium co-transport in the gut pulls water back into the body even during illness, correcting dehydration. World Health Organization+1Early recognition & goal-directed shock care
Description: If blood pressure drops or mental status worsens, teams escalate to rapid IV fluids, vasopressors (see drug section), and close monitoring. Purpose: Reverse shock quickly and prevent organ failure. Mechanism: Restoring volume and supporting vessels maintains perfusion to the brain, kidneys, and heart. cdc.gov+1Oxygen therapy & ventilatory support
Description: Oxygen via nasal cannula or mask; mechanical ventilation if respiratory failure or severe shock develops. Purpose: Keep oxygen levels safe and reduce work of breathing. Mechanism: Ensures enough oxygen reaches tissues while the underlying illness is treated supportively. cdc.govRenal replacement therapy (dialysis) when indicated
Description: Some patients develop kidney failure; hemodialysis or continuous renal replacement therapy may be used in ICU. Purpose: Remove toxins and excess fluid, correct dangerous electrolytes. Mechanism: A dialysis machine filters blood when the kidneys cannot. Mayo ClinicBlood component therapy (as per specialists)
Description: Packed red cells for severe anemia; platelets or plasma for significant bleeding/coagulopathy when benefits outweigh risks. Purpose: Stabilize oxygen-carrying capacity and clotting. Mechanism: Replaces lost cells/clotting factors to control hemorrhage. cdc.govCareful temperature control & comfort measures
Description: Tepid sponging, light bedding, and environmental cooling + antipyretics (see drugs) help fever. Purpose: Reduce discomfort and fluid loss from sweating. Mechanism: Lower fever reduces metabolic strain and dehydration. cdc.govNutrition support
Description: Small, frequent, energy-dense meals if safe; enteral feeding via tube if swallowing is unsafe; parenteral nutrition only when absolutely necessary. Purpose: Maintain energy and immunity. Mechanism: Adequate calories and protein support immune function and healing. e-lactancia.orgInfection prevention for procedures
Description: Limit non-essential invasive lines; use closed systems and strict asepsis. Purpose: Lower risk of secondary bacterial infections. Mechanism: Fewer breaches of skin and fewer device days mean fewer bacterial opportunities. cdc.govAntimicrobial stewardship & sepsis protocols
Description: If bacterial sepsis can’t be excluded, follow local sepsis protocols (cultures, empiric antibiotics), then narrow or stop when results return. Purpose: Treat coinfections without overusing antibiotics. Mechanism: Early appropriate antibiotics reduce mortality in sepsis; stewardship prevents resistance. binasss.sa.crNeurologic care & seizure control
Description: Frequent neuro checks; seizure precautions; escalate to antiseizure meds as needed (per ICU protocols). Purpose: Prevent injury and status epilepticus. Mechanism: Timely seizure control protects brain function. cdc.govPain and nausea control
Description: Use safest options (see drugs) to reduce distress, maintain oral intake, and allow care. Purpose: Comfort, hydration, and compliance. Mechanism: Reducing vomiting and pain prevents worsening dehydration and physiologic stress. cdc.govCare clustering while in PPE
Description: Group tasks to minimize room entries, use checklists, and double-check donning/doffing. Purpose: Reduce PPE errors and conserve staff energy. Mechanism: Fewer exposures and better routines lower transmission risk. cdc.govLaboratory biosafety and safe sample handling
Description: Only essential tests; use point-of-care where feasible; reference labs with high biosafety. Purpose: Protect lab personnel; ensure accurate results. Mechanism: Safe packaging and limited handling reduce exposure. cdc.govContact tracing & exposure management
Description: Identify, inform, and monitor exposed staff/contacts; follow public health guidance for quarantine/monitoring. Purpose: Break transmission chains. Mechanism: Early detection of symptoms among contacts prevents spread. cdc.govEnvironmental cleaning & waste management
Description: Use approved disinfectants; treat waste as high-risk; train cleaning staff in PPE. Purpose: Remove infectious material from the environment. Mechanism: Proper disinfectants inactivate virus on surfaces. cdc.govPsychological support
Description: Reassurance, video calls with family, and mental-health check-ins. Purpose: Reduce anxiety, improve adherence. Mechanism: Lower stress can improve recovery behaviors and staff resilience. e-lactancia.orgEarly specialist consultation (ID/critical care/public health)
Description: Rapid involvement of infectious diseases, ICU, nephrology, and public health. Purpose: Coordinate complex care and isolation. Mechanism: Expertise optimizes supportive therapy and containment. cdc.govEscalation to advanced organ support as needed
Description: ECMO or advanced ventilation only in select centers. Purpose: Bridge extreme respiratory failure. Mechanism: Temporarily oxygenates blood while lungs recover. cdc.gov
Drug treatments
Important: There is no FDA-approved antiviral specifically for Brazilian hemorrhagic fever/Sabiá virus. Most meds below are supportive (fever, nausea, sepsis, shock) and are cited to accessdata.fda.gov labels for accuracy. Any antiviral use is off-label/experimental and must be directed by expert teams and authorities. cdc.gov
Ribavirin (off-label antiviral; evidence from other arenaviruses)
Class: Nucleoside analogue antiviral. Dose/Time: Regimens used for other VHFs vary; no approved BHF dose—expert/compassionate-use only. Purpose: Considered for some arenavirus infections early in illness. Mechanism: Inhibits viral RNA synthesis and promotes error catastrophe. Side effects: Hemolytic anemia; teratogenicity; cardiac risk with anemia. Evidence note: Data for Lassa and Argentine HF are mixed; not FDA-approved for BHF. Label source (HCV indication): COPEGUS. PMC+2FDA Access Data+2Favipiravir (T-705) (investigational/off-label)
Class: RNA polymerase inhibitor. Dose/Time: Research use only; not FDA-approved. Purpose: Experimental for arenaviruses in animal models. Mechanism: Lethal mutagenesis/chain termination in RNA viruses. Side effects: Teratogenicity in animals; GI effects. Evidence: Protected arenavirus-infected guinea pigs in studies; human data lacking for BHF. PLOS+2PMC+2Norepinephrine (for septic shock)
Class: Vasopressor. Dose/Time: Titrated IV infusion to maintain perfusion pressure. Purpose: Raises blood pressure in shock after fluids. Mechanism: Alpha-adrenergic vasoconstriction. Key risks: Arrhythmias, limb ischemia. Label: Norepinephrine in sodium chloride injection. FDA Access DataAcetaminophen/Paracetamol (fever/pain)
Class: Analgesic/antipyretic. Dose/Time: Oral/IV per label; avoid overdose and consider liver risk. Purpose: Reduces fever and pain to improve comfort and hydration. Mechanism: Central prostaglandin synthesis modulation. Risks: Hepatotoxicity if cumulative dose exceeded. Label: OFIRMEV/Acetaminophen Injection. FDA Access DataOndansetron (anti-nausea)
Class: 5-HT3 antagonist. Dose/Time: IV/PO per label. Purpose: Controls vomiting to maintain fluids/meds. Mechanism: Blocks serotonin receptors in gut/brain. Risks: QT prolongation, headaches. Label: ZOFRAN. FDA Access DataPantoprazole (stress ulcer prophylaxis if indicated)
Class: Proton-pump inhibitor. Dose/Time: IV per label if NPO. Purpose: Protects GI lining in critically ill patients. Mechanism: Blocks acid secretion (H⁺/K⁺-ATPase). Risks: C. difficile risk, hypomagnesemia, rare nephritis. Label: Pantoprazole injection. FDA Access DataPiperacillin-tazobactam (empiric sepsis coverage if bacterial infection suspected)
Class: Broad-spectrum β-lactam/β-lactamase inhibitor. Dose/Time: IV per label; adjust for renal function. Purpose: Treats possible bacterial coinfection while awaiting cultures. Mechanism: Inhibits cell wall synthesis + protects from β-lactamases. Risks: Allergy, renal effects. Label: ZOSYN. FDA Access DataVancomycin (add for MRSA risk per local protocols)
Class: Glycopeptide antibiotic. Dose/Time: IV per label; trough-guided. Purpose: MRSA coverage if indicated. Mechanism: Inhibits cell wall synthesis. Risks: Infusion reactions, nephrotoxicity. Label: Vancomycin Injection. FDA Access DataCeftriaxone (alternative broad coverage depending on syndrome)
Class: 3rd-generation cephalosporin. Dose/Time: IV per label. Purpose: Community-acquired sepsis/meningitis patterns per guidance. Mechanism: Cell wall inhibition. Risks: Allergy, biliary sludging. Label: Ceftriaxone for Injection. FDA Access DataDoxycycline or azithromycin (when rickettsial/atypical coverage is needed)
Class: Tetracycline/macrolide. Purpose/Mechanism: Coverage for alternate diagnoses early in evaluation; follow local protocols. Risks: Photosensitivity (doxy), QT prolongation (azithro). Label sources exist on FDA; use per indications, not for BHF. (Context: empiric fever management while VHF is considered.) doh.wa.govElectrolyte replacements (potassium, magnesium)
Class: Electrolytes. Purpose: Correct hypokalemia/hypomagnesemia due to vomiting/diarrhea. Mechanism: Restores cellular function and heart rhythm stability. Use: Per hospital protocols and labs. World Health OrganizationAnticonvulsants (e.g., levetiracetam) if seizures occur
Purpose/Mechanism: Stabilize neuronal firing to prevent status epilepticus. Use: ICU protocols; not disease-specific. cdc.govAntipyretic rotation (acetaminophen preferred; avoid NSAIDs if bleeding risk)
Purpose: Fever control with minimal bleeding risk; NSAIDs are generally avoided in hemorrhagic states. Mechanism: See acetaminophen above. cdc.govAntidiarrheals generally avoided
Purpose: Avoid masking severe illness or precipitating complications; follow specialist advice. Mechanism: Slowing gut may be harmful in certain infections. World Health OrganizationAntiemetics (ondansetron preferred)
Purpose/Mechanism: Reduce vomiting to support ORS/PO intake (see #5). FDA Access DataInsulin sliding scale if stress hyperglycemia appears
Purpose: Maintain glucose in safe range during critical illness. Mechanism: Prevents osmotic diuresis and worsened dehydration. cdc.govProphylactic anticoagulation is often withheld if active bleeding/high risk
Purpose: Avoid worsening hemorrhage; decisions individualized. Mechanism: Anticoagulants reduce clots but can exacerbate bleeding in VHFs. cdc.govEmpiric antimalarials in endemic differential (context-specific)
Purpose: If malaria can’t be excluded immediately, treat per local malaria guidelines while evaluating VHF. Mechanism: Clears Plasmodium parasites. e-lactancia.orgProton-pump inhibitor (see #6) or H2 blocker
Purpose: Stress-related mucosal protection if indicated. Mechanism: Reduces gastric acid to lower bleeding risk from erosions. FDA Access DataBroad infectious-disease consultation for investigational antivirals
Purpose: Evaluate eligibility for research protocols (e.g., favipiravir kits) and compassionate-use pathways under authorities’ oversight. Mechanism: Access to monitored, ethical off-label therapy. PLOS
Dietary molecular supplements
None of these treat BHF. They may support recovery only if a clinician says they’re safe for the patient’s liver, kidneys, and bleeding risk.
Oral Rehydration Salts (WHO formula) — Dose: As directed on sachet; small, frequent sips. Function/Mechanism: Glucose-sodium transport drives water absorption; replaces electrolytes lost to fever/vomiting. World Health Organization
Zinc (co-pack with ORS in diarrhea programs) — Dose: Typically 10–20 mg/day for short courses in diarrhea per WHO/UNICEF (contextual; clinician-directed in VHF). Function: Supports mucosal integrity and immune function. Mechanism: Enzymatic cofactor; may reduce diarrheal losses, aiding hydration. UNICEF
Thiamine (Vitamin B1) — Dose: Standard hospital supplementation if malnourished or prolonged vomiting. Function: Supports cellular energy. Mechanism: Cofactor for carbohydrate metabolism. e-lactancia.org
Folate/B-complex — Dose: Per nutrition team. Function: Red blood cell production support in prolonged illness. Mechanism: DNA/RNA synthesis cofactors. e-lactancia.org
Vitamin C — Dose: Typical daily allowance unless contraindicated. Function: Antioxidant; collagen synthesis. Mechanism: Supports capillary integrity; evidence for VHF outcomes is lacking. e-lactancia.org
Vitamin D — Dose: Routine deficiency replacement only. Function: Immune modulation and bone health. Mechanism: Nuclear receptor signaling; outcome benefit in VHF unproven. e-lactancia.org
Protein-rich oral supplements — Dose: As diet tolerated. Function: Tissue repair and immune proteins. Mechanism: Supplies amino acids for healing. e-lactancia.org
Electrolyte gel packs (K/Mg as ordered) — Function/Mechanism: Replace measured deficits; stabilize heart rhythm and muscles. World Health Organization
Probiotics are not recommended routinely — Reason: Safety/benefit uncertain in critically ill or immunocompromised patients. e-lactancia.org
Caution with herbal products — Reason: Many increase bleeding risk or interact with ICU drugs; avoid unless clinician approves. cdc.gov
Immunity-booster / regenerative / stem-cell drugs
There are no approved “immune-boosting” or stem-cell drugs for BHF. Below are concepts sometimes raised, with why they’re not standard.
Convalescent plasma (passive antibodies) — Used historically in Argentine hemorrhagic fever, not BHF; any use would be research-only with risks (TRALI, infections). Mechanism: Donor antibodies neutralize virus. European Medicines Agency (EMA)
Monoclonal antibodies (investigational) — For Sabiá virus, none approved; theoretical neutralization. Mechanism: Bind viral glycoproteins to block entry. Research only. binasss.sa.cr
Interferons — Broad antiviral signaling; toxicity limits and unproven benefit in BHF. Research context only. binasss.sa.cr
Favipiravir — (see above) investigational antiviral; not an immune booster or stem-cell drug; included here to clarify it’s experimental. PLOS
Mesenchymal stem cells — No evidence or approval in VHFs; not recommended. binasss.sa.cr
Growth factors (e.g., EPO, G-CSF) — Used for specific conditions (anemia, neutropenia) but not for VHF; balance risks with specialists. binasss.sa.cr
Surgeries or procedures
Central venous catheter insertion — For vasopressors/dialysis; done with maximal barrier precautions to limit exposures. Why: Shock requiring continuous support. cdc.gov
Endotracheal intubation & ventilation — For respiratory failure; use airborne precautions and experienced staff. Why: Life-saving oxygenation/ventilation. cdc.gov
Dialysis catheter placement — To enable renal replacement in kidney failure. Why: Remove toxins and fluid when kidneys fail. Mayo Clinic
Emergency bleeding control (endoscopy/intervention) — Only if benefits outweigh risks and in proper PPE. Why: Stop life-threatening hemorrhage. cdc.gov
Obstetric procedures if essential — Manage hemorrhage or complications with full precautions. Why: Maternal/fetal survival. cdc.gov
Prevention points
Avoid contact with blood/body fluids of ill persons; use PPE if caring for them. cdc.gov
Healthcare isolation: negative-pressure rooms when available. cdc.gov
Hand hygiene: alcohol-based rubs or soap/water after any contact. cdc.gov
Safe needles/sharps: no recapping; proper disposal. cdc.gov
Environmental cleaning with effective disinfectants; proper waste handling. cdc.gov
Public health reporting of suspected cases for contact tracing. cdc.gov
Limit procedures to essential ones to reduce exposure risk. cdc.gov
Rodent control & hygiene (general arenavirus caution). cdc.gov
Laboratory biosafety: send specimens only to authorized labs. cdc.gov
Community education during investigations (what symptoms to report). cdc.gov
When to see a doctor
Seek urgent medical help if you have fever plus any bleeding, severe vomiting/diarrhea, fainting, severe weakness, confusion, seizures, or if you had close contact with a person under investigation for a viral hemorrhagic fever. In healthcare settings, immediately isolate and notify infection control and public health. Early supportive care—fluids, oxygen, monitoring—saves lives even without a specific antiviral. cdc.gov+1
What to eat & what to avoid
What to eat :
• Oral rehydration solution sipped often; small, soft meals.
• Bananas, rice, toast, applesauce (gentle, easy to digest).
• Broths and soups for fluids/salt.
• Yogurt if tolerated (protein, calories).
• Lean proteins (eggs, fish, chicken) for healing.
• Cooked vegetables and soft fruits for vitamins.
• Fortified porridges/congee as culturally appropriate.
• Energy-dense oral nutrition drinks as advised.
• Electrolyte-containing beverages (not sports drinks for kids unless directed).
• Frequent, small portions to reduce nausea. World Health Organization
What to avoid :
• Alcohol (dehydrating, liver stress).
• NSAIDs (e.g., ibuprofen) unless a clinician specifically okays—bleeding risk.
• Raw or undercooked foods (infection risk).
• Very spicy/fatty meals (worsen nausea).
• Unregulated herbal products (drug interactions, bleeding).
• High-caffeine drinks (dehydrating, vomiting).
• Large single meals (trigger vomiting).
• Sugary sodas instead of ORS (wrong osmolarity).
• Unboiled water in outbreak settings.
• Self-medication without medical advice. World Health Organization
FAQs
1) Is there a cure for Brazilian hemorrhagic fever?
No. There’s no specific FDA-approved antiviral for Sabiá virus. Care is supportive and can be lifesaving. cdc.gov
2) Is ribavirin a proven treatment?
Ribavirin has mixed evidence in other arenaviruses and is not approved for BHF; experts may consider off-label use early in select cases. PMC
3) What about favipiravir?
It helped in animal models of arenavirus disease but is investigational for BHF. PLOS
4) How dangerous is BHF?
It can be severe; a majority of reported cases were fatal in early literature, though numbers are very small. Canada.ca
5) How does it spread?
Likely via contact with blood/body fluids and possibly rodent exposure (like other arenaviruses). Hospital transmission is prevented with strict PPE. cdc.gov
6) Can I take ibuprofen for fever?
Avoid NSAIDs when bleeding risk is high; acetaminophen is usually preferred—only as guided by clinicians. cdc.gov
7) Why is fluid therapy emphasized so much?
Because dehydration and shock are major killers in VHFs; fluids and electrolytes keep organs perfused. cdc.gov
8) Do antibiotics help a virus?
They don’t kill viruses, but may be used empirically if bacterial sepsis is possible—then narrowed based on cultures. binasss.sa.cr
9) Are there vaccines for BHF?
No licensed human vaccine for Sabiá virus. Prevention is exposure control and public-health containment. Canada.ca
10) Is dialysis ever needed?
Yes, if kidneys fail; it’s supportive care in ICU. Mayo Clinic
11) Can convalescent plasma help?
It’s been used for Argentine hemorrhagic fever; for BHF there’s no established therapy—research-only. European Medicines Agency (EMA)
12) Why the intense PPE?
To protect staff and prevent hospital outbreaks—standard for VHFs. cdc.gov
13) Is BHF contagious before symptoms?
Data are limited; isolation is started as soon as VHF is suspected. cdc.gov
14) Where can clinicians find practical care tips?
WHO’s pocket guides and CDC VHF pages summarize supportive care, fluids, and PPE. World Health Organization+1
15) Has BHF been seen recently?
Sporadic arenavirus hemorrhagic fever cases—including Sabiá-like viruses—have been reported in Brazil in recent years, underscoring the need for vigilance. PMC+1.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: November 02, 2025.
